• Title of article

    Effect of vesnarinone on cardiac function in patients with severe congestive heart failure, ,

  • Author/Authors

    Marielle Scherrer-Crosbie، نويسنده , , Diane Cocca-Spofford، نويسنده , , Thomas G. DiSalvo، نويسنده , , Marc J. Semigran*، نويسنده , , G.William Dec، نويسنده , , Michael H. Picard، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 1998
  • Pages
    9
  • From page
    769
  • To page
    777
  • Abstract
    Background Vesnarinone has yielded controversial results on morbidity in patients with congestive heart failure. We tested the hypothesis that vesnarinone may have a beneficial effect on cardiac remodeling and function. Methods Thirty-four patients with left ventricular ejection fraction (LVEF) <30% (17 treated with vesnarinone) underwent an echocardiography at baseline and at 12 ± 5 months. Left ventricular end-diastolic and end-systolic volume, mitral regurgitation, diastolic filling, and right ventricular area change were quantified and compared. Results When the vesnarinone group was considered as a whole, there was no significant effect of vesnarinone on cardiac systolic and diastolic function or remodeling. However, an increase in LVEF >7% was observed in six of the vesnarinone patients and none of the control group. Vesnarinone improved right and left ventricular systolic function significantly in patients with initial LVEF <25%. Conclusions In severe congestive heart failure, vesnarinone induces variable responses but improves biventricular performance in patients with the most impaired initial function. (Am Heart J 1998;136:769-77.)
  • Journal title
    American Heart Journal
  • Serial Year
    1998
  • Journal title
    American Heart Journal
  • Record number

    531379